Yong Han1, Min Chen1, Hangzhou Wang2. 1. Department of Neurosurgery, Children's Hospital of Soochow University, 92 Zhongnan Street, Suzhou, Jiangsu, 215006, People's Republic of China. 2. Department of Neurosurgery, Children's Hospital of Soochow University, 92 Zhongnan Street, Suzhou, Jiangsu, 215006, People's Republic of China. 13771843695@163.com.
Abstract
PURPOSE: Lateral meningocele syndrome (LMS) is a rare genetic connective tissue disorder which is associated with meningocele-related neurologic dysfunction. Several patients with LMS have been reported. But, guidelines for screening and treatment of LMS have not been established. METHOD AND RESULTS: We review the current knowledge of LMS in the article. Then, we describe a boy for whom a genomic analysis which allowed us to make a diagnosis of LMS and to begin monitoring of his condition for possible neurological complications. CONCLUSION: It would be difficult to make a diagnosis of LMS on the basis of clinical manifestations alone. The natural history of dural ectasia in patients with LMS needs to be better defined to establish surgical indications. Based upon the current literature, ventriculoperitoneal shunting (V-Ps) has been recommended as the first-line surgical treatment option for patients with symptomatic thoracolumbar meningoceles.
PURPOSE: Lateral meningocele syndrome (LMS) is a rare genetic connective tissue disorder which is associated with meningocele-related neurologic dysfunction. Several patients with LMS have been reported. But, guidelines for screening and treatment of LMS have not been established. METHOD AND RESULTS: We review the current knowledge of LMS in the article. Then, we describe a boy for whom a genomic analysis which allowed us to make a diagnosis of LMS and to begin monitoring of his condition for possible neurological complications. CONCLUSION: It would be difficult to make a diagnosis of LMS on the basis of clinical manifestations alone. The natural history of dural ectasia in patients with LMS needs to be better defined to establish surgical indications. Based upon the current literature, ventriculoperitoneal shunting (V-Ps) has been recommended as the first-line surgical treatment option for patients with symptomatic thoracolumbar meningoceles.
Authors: Karen W Gripp; Katherine M Robbins; Nara L Sobreira; P Dane Witmer; Lynne M Bird; Kristiina Avela; Outi Makitie; Daniela Alves; Jacob S Hogue; Elaine H Zackai; Kimberly F Doheny; Deborah L Stabley; Katia Sol-Church Journal: Am J Med Genet A Date: 2014-11-13 Impact factor: 2.802
Authors: Resham Ejaz; Wen Qin; Lijia Huang; Susan Blaser; Martine Tetreault; Taila Hartley; Kym M Boycott; Melissa T Carter Journal: Am J Med Genet A Date: 2016-01-11 Impact factor: 2.802
Authors: Marco Castori; Silvia Morlino; Marco Ritelli; Francesco Brancati; Carmelilia De Bernardo; Marina Colombi; Paola Grammatico Journal: Am J Med Genet A Date: 2013-12-05 Impact factor: 2.802
Authors: Joshua A Cuoco; Brendan J Klein; Christopher M Busch; Hailey L Gosnell; Ayesha Kar; Eric A Marvin; Lisa S Apfel Journal: Pediatr Neurosurg Date: 2019-12-13 Impact factor: 1.162